MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia
β Scribed by E.W. Fleischman; S. Reshmi; M.A. Frenkel; W.I. Konovalova; G.P. Guleva; O.E. Kulagina; L.N. Konstantinova; N.N. Tupitsyn; J.D. Rowley
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 173 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
We describe a patient with acute myeloblastic leukemia (AML-M0) whose cells had a t(2;11)(p21;q23). Fluorescence in situ hybridization analysis with a probe for MLL showed that it was split, hybridizing to both the derivative 2 and 11 chromosomes. Nineteen other patients with 2p;11q translocations have been described; breakpoints in 14 of these are the same as in the case we describe. The phenotype of these patients is quite variable, with 14 patients having myelodysplastic syndrome which evolved to AML in six. Four patients had AML and two had acute lymphoblastic leukemia. MLL status has been studied in two other patients; one had MLL rearranged and one did not.
π SIMILAR VOLUMES
A new case of translocation t(6;11)(q21;q23) in a patient with therapy-related acute myeloblastic leukemia is reported. The translocation results in fusion of the MLL and AF6q21 genes. The breakpoint with AF6q21 is located within the sequences encoding the AF6q21 fork head motif. The similar locatio
To the Editor: Idiopathic thrombotic thrombocytopenic purpura (TTP) is a lifethreatening disease characterized by thrombocytopenia, microangiopathic hemolytic anemia, fever, neurologic changes, and renal dysfunction and is related to autoantibodies against von Willebrand factor cleaving metalloprote
We describe a boy with Fanconi anemia (FA) who developed acute lymphoblastic leukemia (ALL) (FAB-L1) followed by acute myeloid leukemia (AML) (FAB-M5) at relapse. The patient was diagnosed with early pre-B-cell ALL without preceding aplastic anemia and was treated with ALL-oriented chemotherapy whic
We report on an adult patient with de novo acute myeloid leukemia (AML) with a t(11;22)(q23;q11.2) involving CDCREL1 and MLL genes. Reverse transcriptase (RT)-polymerase chain reaction (PCR) followed by direct sequencing analysis revealed the MLL-CDCREL1 fusion transcript in his leukemic cells. Anal